Literature DB >> 7084485

Hemodynamic factors in the pathogenesis and maintenance of hypertension.

E D Frohlich.   

Abstract

Hypertension is not simply an acute elevation of arterial pressure during a laboratory experiment. It is the development of a cardiovascular disorder provoking a variety of physiological adaptions brought about by an imbalance of pressor and depressor mechanisms that serve to control arterial pressure at normal levels in the normotensive animal. These pathogenetic mechanisms include hemodynamic, volume, renal parenchymal, sodium, renopressor, catecholamine, neural, hormonal, and even depressor factors. The most common form of the disease is essential hypertension, affecting over 95% of patients with hypertension. Although not the same, the experimental animal model that best mimics essential hypertension is the spontaneously hypertensive rat (SHR). However, to state with certainty that the SHR is a true laboratory duplicate of essential hypertension is inaccurate because the causes of both diseases remain unknown. Both forms are genetically predisposed, naturally occurring, slow but progressive in development, and similar in cardiovascular and hemodynamic adaptions. Both involve arteriolar and venular constriction and myocardial hypertrophy that provide a stable hyperfunctioning adaptation of the heart for a substantial period of time but ultimately lead to cardiac failure, stroke, and other vascular impairment. At best we can conclude that they both represent genetically predisposed disease that involves the disarray of the multifactorial interplay of mechanisms that usually maintain arterial pressure at normal levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7084485

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  9 in total

Review 1.  When is discontinuation of antihypertensive therapy indicated?

Authors:  R E Schmieder; J K Rockstroh
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

2.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

3.  Correction of physiological alterations of hypertension.

Authors:  E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

4.  An updated concept for left ventricular hypertrophy risk in hypertension.

Authors:  Edward D Frohlich
Journal:  Ochsner J       Date:  2009

5.  Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.

Authors:  U H Rudofsky; R L Dilwith; J B Roths; D A Lawrence; V E Kelley; A M Magro
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

Review 6.  Management of diabetic and hypertensive cardiovascular disease.

Authors:  Edward D Frohlich; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 7.  Physical activity in human hypertension. A mechanisms approach.

Authors:  W L Kenney; E J Zambraski
Journal:  Sports Med       Date:  1984 Nov-Dec       Impact factor: 11.136

Review 8.  Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension.

Authors:  Edward D Frohlich; Dinko Susic
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

Review 9.  Management of essential hypertension in the black patient: profiling as the initial approach to treatment.

Authors:  F H Messerli
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.